Compass Ion Advisors
TMO icon

Compass Ion Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Compass Ion Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$388K Buy
+575
New +$342K 0.03% 213

Other funds holding TMO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Compass Ion Advisors's TMO Position: Q3 2026 in Review

Compass Ion Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 575 shares worth $388K. The stake represents 0.03% of the portfolio and ranks #213 among its holdings.

2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Compass Ion Advisors held 575 shares of Thermo Fisher Scientific worth $388K as of Q3 2026.
  • Thermo Fisher Scientific was a new Compass Ion Advisors position in Q3 2026.
  • Thermo Fisher Scientific made up 0.03% of Compass Ion Advisors's portfolio in Q3 2026, its #213 holding.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Compass Ion Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.